Home // Research // FSTC // Life Science... // Cytoskeleton... // Publications

Recent peer-reviewed original publications

  1. Vetter, G., A. Saumet, M. Moes, L. Vallar, A. Le Bechec, C. Laurini, M. Sabbah, K. Arar, C. Theillet, C.H. Lecellier, and E. Friederich. miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers. Oncogene. 29:4436-48.
  2. Al Tanoury, Z., E. Schaffner-Reckinger, A. Halavatyi, C. Hoffmann, M. Moes, E. Hadzic, M. Catillon, M. Yatskou, and E. Friederich. (2010) Quantitative kinetic study of the actin-bundling protein L-plastin and of its impact on actin turn-over. PLoS One. 5:e9210.
  3. Delanote, V., B. Vanloo, M. Catillon, E. Friederich, J. Vandekerckhove, and J. Gettemans. (2009) An alpaca single-domain antibody blocks filopodia formation by obstructing L-plastin-mediated F-actin bundling. Faseb J. 24:105-18.
  4. Halavatyi, A.A., P.V. Nazarov, Z. Al Tanoury, V.V. Apanasovich, M. Yatskou, and E. Friederich. (2009) A mathematical model of actin filament turnover for fitting FRAP data. Eur Biophys J. 39:669-77.
  5. Janji, B., L. Vallar, Z. Al-Tanoury, F. Bernardin, G. Vetter, E. Schaffner-Reckinger, G. Berchem, E. Friederich, and S. Chouaib. (2009) The actin filament cross-linker L-plastin confers resistance to TNF-alpha in MCF-7 breast cancer cells in a phosphorylation-dependent manner. J Cell Mol Med.
  6. Vetter, G., Le Bechec, A., Muller, J., Muller, A., Moes, M., Yatskou, M., Al Tanoury, Z., Poch, O., Vallar, L. and Friederich, E. (2009). Time-resolved analysis of transcriptional events during SNAI1-triggered epithelial to mesenchymal transition. Biochem Biophys Res Commun 385, 485-91.
  7. Saumet, A., G. Vetter, M. Bouttier, E. Portales-Casamar, W.W. Wasserman, T. Maurin, B. Mari, P. Barbry, L. Vallar, E. Friederich, K. Arar, B. Cassinat, C. Chomienne, and C.H. Lecellier. (2009). Transcriptional repression of microRNA genes by PML-RARA increases expression of key cancer proteins in acute promyelocytic leukemia. Blood 113:412-21.
  8. Halavatyi, A., Nazarov, , P., Medves, S., van Troys, M., Ampe C., Yatskou, M., E. Friederich. (2008) An Integrative Simulation Model Linking Major Biochemical reactions of actin-polymerization to structural properties of actin filaments. Biophys. Chem. 140:24-34.
  9. Yatskou, M., E. Novikov, G. Vetter, A. Muller, E. Barillot, L. Vallar, and E. Friederich. (2008). Advanced spot quality analysis in two-colour microarray experiments. BMC Res Notes. 1:80.
  10. Gay, F., Y. Estornes, J.C. Saurin, M.O. Joly-Pharaboz, E. Friederich, J.Y. Scoazec, and J. Abello. (2008) In colon carcinogenesis, the cytoskeletal protein gelsolin is down-regulated during the transition from adenoma to carcinoma. Hum Pathol. 39, 1420-30.
  11. Muller, J., A. Mehlen, G. Vetter, M. Yatskou, A. Muller, F. Chalmel, O. Poch, E. Friederich, and Vallar, L. (2007) Design and evaluation of Actichip, a thematic microarray for the study of the actin cytoskeleton. BMC Genomics, 8, 294
  12. Stoetzel, C., J. Muller, V. Laurier, E.E. Davis, N.A. Zaghloul, S. Vicaire, C. Jacquelin, F. Plewniak, C.C. Leitch, P. Sarda, C. Hamel, T.J. de Ravel, R.A. Lewis, E. Friederich, C. Thibault, J.M. Danse, A. Verloes, D. Bonneau, N. Katsanis, O. Poch, J.L. Mandel, and Dollfus, H. (2007) Identification of a novel BBS gene (BBS12) highlights the major role of a vertebrate-specific branch of chaperonin-related proteins in Bardet-Biedl syndrome. Am J Hum Genet. 80, 1-11
  13. Phosphorylation on Serine 5 increases the F-actin-bundling activity of L-plastin and promotes its targeting to sites of actin assembly in cells. (2006) Janji, B., Giganti, A., De Corte, V., Catillon, M., Bruyneel, E., Lentz, D., Plastino, J., Gettemans, J., and E. Friederich, E. J.Cell Sci. 119, 1947-60
  14. Molecular basis for dissimilar nucleo-plasmic trafficking of the actin bundling isoforms T-and L-plastin. (2005) Delanote, V., Van Impe, K., De Corte, V., Bruyneel, E., Vetter, G., Boucherie, C., Mareel, M., Vandekerckhove, J., Friederich, E., and Gettemans, J. J. Traffic. 6, 1-11
  15. Sequence and comparative genomics analysis of actin related Proteins in the eukaryotic phyla highlight the central role of nuclear ARPs. (2005) Muller, J., Oma, Y., Vallar, L., Friederich, E, Poch, Olivier and B. Winsor, B. Mol. Biol. Cell. 16, 5736-5748
  16. Actin-filament cross-linking protein T-fimbrin increases Arp2/3-mediated actin-based movement. (2005) Giganti, A., Plastino, J., Janji, B., Van Troys, M., Lentz, D., Ampe, C., Sykes, C. and Friederich, E. J. Cell Sci. 118, 1255-1265.

Review articles and book chapters

  1. Friederich, E. (2007) Special issue: Integrated approaches to cytoskeleton research. Biochim Biophys Acta. 1773:603.
  2. Microvilli. Friederich, E. and D. Louvard, D. (2006) In Encyclopedic Reference of Genomics. Springer Verlag
  3. The actin cytoskeleton as a therapeutic target: state of the art and future directions. (2003) Giganti A. and Friederich, E. Chapter in Progress in Cell Cycle Research 5, 511-525.
  4. Anne Saumet, Guillaume Vetter, Nicolas Cougot, Manuella Bouttier, Florence Rage,Khalil Arar and Charles-Henri Lecellier. “MiRNAs associated therapies”. Current Research and Perspectives in MicroRNAs. Springer Biomedical Sciences

Patent applications (2009)

  1. MiRNA AS A PROGNOSTIC, DIAGNOSTIC BIOMARKER AND THERAPEUTIC AGENT FOR BREAST CANCER AND OTHER HUMAN ASSOCIATED PATHOLOGIES P-UNILU-004/LU (co-inventors Guillaume Vetter, Evelyne Friederich)
  2.  PLASTIN ANTIBODIES AND THEIR USE-US 61/210,819 (co-inventors Jan Gettemans, VIB – University of Ghent, Evelyne Friederich)